Sporacid 100mg capsules
Ferron Par Pharmaceuticals
Ingredients in every capsule
| Itraconazole | 100 mg |
Each package contains
1 strip of 10 capsules
Dosage form
 |
capsule |
Dosage formCapsule; hard
Flavour
None
W.H.O. classification
J02A
J02A
A.T.C. Level 1
Anatomical Main group
J - Antiinfectives for systemic use
J02A
A.T.C. Level 2
Therapeutic subgroup
J02 - Antimycotics for Systemic Use
J02A
A.T.C. Level 3
Pharmacological subgroup
J02A - Antimycotics for Systemic Use
Available in
 |
Indonesia |
 |
Myanmar |
 |
Cambodia |
Warnings
Alcohol
CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.
Machinery
CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution and after consultation with your doctor.
Pregnancy
NOT RECOMMENDEDThis item is not safe for use during pregnancy.
Lactation
NOT RECOMMENDEDThis item is not safe for use during lactation.
Indication
For short-term therapy
– Vulvovaginal candidiasis
– Pityriasis versicolor
– Dermatomycosis
– Fungal Keratitis
– Oral Candidiasis
For long-term therapy
Onychomycosis and systemic mycosis such as:
– Aspergillosis
– Candidiasis
– Cryptococcosis (including cryptococcal meningitis)
– Histoplasmosis
– Sporotrichosis
– Paracoccidioidomycosis
– Systemic blastomycosis.
– Vulvovaginal candidiasis
– Pityriasis versicolor
– Dermatomycosis
– Fungal Keratitis
– Oral Candidiasis
For long-term therapy
Onychomycosis and systemic mycosis such as:
– Aspergillosis
– Candidiasis
– Cryptococcosis (including cryptococcal meningitis)
– Histoplasmosis
– Sporotrichosis
– Paracoccidioidomycosis
– Systemic blastomycosis.
Dosage
18 YEARS OLD AND ABOVE
Duration of therapy depends on the type of infection:
— Superficial fungal infections:
> Tinea corporis/cruris and oral candidiasis: 100 mg, once daily during meal time, for 15 days
> Tinea pedis/manus: 100 mg, once daily during meal time, for 30 days
> Pityriasis versicolor: 200 mg, once daily, for 7 days
> Vulvovaginal candidiasis: 200 mg, once daily, for 3 days
> Fungal keratitis: 200 mg, once daily, for 3 weeks
— Onychomicosis: 2 capsules (200 mg), once daily, for 3 months or pulse therapy. A pulse treatment consists of two capsules twice daily (200 mg b.i.d.) for one week.
PATIENTS WITH IMPAIRED HEPATIC FUNCTION
Itraconazole is metabolized especially in the liver. Although in studies, liver function disorder has not been reported, it should not be given to patients with hepatic disorders or hepatotoxic patients with other drugs.
Duration of therapy depends on the type of infection:
— Superficial fungal infections:
> Tinea corporis/cruris and oral candidiasis: 100 mg, once daily during meal time, for 15 days
> Tinea pedis/manus: 100 mg, once daily during meal time, for 30 days
> Pityriasis versicolor: 200 mg, once daily, for 7 days
> Vulvovaginal candidiasis: 200 mg, once daily, for 3 days
> Fungal keratitis: 200 mg, once daily, for 3 weeks
— Onychomicosis: 2 capsules (200 mg), once daily, for 3 months or pulse therapy. A pulse treatment consists of two capsules twice daily (200 mg b.i.d.) for one week.
PATIENTS WITH IMPAIRED HEPATIC FUNCTION
Itraconazole is metabolized especially in the liver. Although in studies, liver function disorder has not been reported, it should not be given to patients with hepatic disorders or hepatotoxic patients with other drugs.